Stocks › PAHC
PHIBRO ANIMAL HEALTH CORP
PAHC·Nasdaq·
United States·USD
United States·USD$37.72
+1.11 (+3.03%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
PAHC
PHIBRO ANIMAL HEALTH CORP · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
PAHCS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of PAHC by members of U.S. Congress · 22 on record
Whale Activity
Position changes in PAHC reported for 2026-06-30 by 10 tracked institutional filers
- Increased4
- New1
- Held0
- Decreased3
- Closed1
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 3.2M | $101.1M | decreased |
| MILLENNIUM MANAGEMENT LLC | 936.7K | $29.4M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 923.3K | $29.0M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 508.5K | $16.0M | increased |
| RENAISSANCE TECHNOLOGIES LLC | 480.5K | $15.1M | decreased |
| GLOBEFLEX CAPITAL L P | 189.2K | $5.9M | — |
| D. E. Shaw & Co., Inc. | 27.3K | $856K | increased |
| TWO SIGMA INVESTMENTS, LP | 17.3K | $543K | decreased |
| CITADEL ADVISORS LLC | 14.9K | $468K | new |
| Point72 Asset Management | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by PAHC insiders, by quarter · Form 4
Recent Insider Transactions
961 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| CORCORAN E THOMASDirector | Purchase | +10.0K | $31.77 | $318K | May 29, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −2,029 | $49.19 | $100K | May 7, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −1,149 | $48.31 | $56K | May 7, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −1,350 | $47.59 | $64K | May 7, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −1,406 | $58.13 | $82K | May 6, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −5,634 | $57.18 | $322K | May 6, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −776 | $56.37 | $44K | May 5, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −6,264 | $55.73 | $349K | May 5, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −1,235 | $53.32 | $66K | Apr 30, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −5,805 | $52.65 | $306K | Apr 30, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −3,038 | $53.21 | $162K | Apr 29, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −4,002 | $52.70 | $211K | Apr 29, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −797 | $56.69 | $45K | Apr 28, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −4,591 | $56.06 | $257K | Apr 28, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −1,652 | $55.10 | $91K | Apr 28, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −421 | $54.56 | $23K | Apr 23, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −6,619 | $54.07 | $358K | Apr 23, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −7,040 | $54.29 | $382K | Apr 22, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −5,415 | $56.17 | $304K | Apr 21, 2026 | Form 4 ↗ |
| BENDHEIM JACKPresident and CEO · Director · 10% owner | Sale | −1,625 | $55.35 | $90K | Apr 21, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding PAHC · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF iShares Trust | 1.3M | $39.9M | 0.04% | Jun 30, 2026 |
| Fidelity Low-Priced Stock Fund Fidelity Puritan Trust | 792.4K | $28.8M | 0.12% | Jul 31, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 659.6K | $20.7M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 548.8K | $17.2M | 0.02% | Jun 30, 2026 |
| Lord Abbett Value Opportunities Fund LORD ABBETT SECURITIES TRUST | 343.8K | $12.5M | 1.12% | Jul 31, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 391.4K | $12.1M | 0.00% | May 31, 2026 |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 289.7K | $10.5M | 0.12% | Jul 31, 2026 |
| Oberweis Micro-Cap Fund OBERWEIS FUNDS | 300.2K | $9.4M | 0.58% | Jun 30, 2026 |
| Nuveen Quant Small Cap Equity Fund TIAA-CREF Funds | 241.4K | $8.8M | 0.22% | Jul 31, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 229.7K | $8.3M | 0.02% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list PAHC's shares (CUSIP 71742Q106), each fund at its latest report since Mar 8, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 3.2M shares15.0%
Aug 6, 2026 · ↗ - FMR LLCSCHEDULE 13G/A · passive (13G) · 3.2M shares15.0%
Aug 6, 2026 · ↗ - Israel A. EnglanderSCHEDULE 13G · passive (13G) · 1.1M shares5.1%
Jul 30, 2026 · ↗ - Millennium Group Management LLCSCHEDULE 13G · passive (13G) · 1.1M shares5.1%
Jul 30, 2026 · ↗ - Millennium Management LLCSCHEDULE 13G · passive (13G) · 1.1M shares5.1%
Jul 30, 2026 · ↗ - Jack C. BendheimSCHEDULE 13D/A · activist (13D) · 19.6M shares48.2%
May 22, 2026 · ↗ - BFI Co., LLCSCHEDULE 13D/A · activist (13D) · 19.6M shares48.2%
May 22, 2026 · ↗ - Barclays PLCSCHEDULE 13G/A · passive (13G) · 263.7K shares1.3%
May 14, 2026 · ↗ - Vanguard Capital ManagementSCHEDULE 13G · passive (13G) · 1.0M shares5.1%
Apr 30, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming phibro animal health as client
- MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M & W GOVERNMENT AFFAIRS, LLC)PHIBRO ANIMAL HEALTH CORPORATION · 2026 Q2 · AGR$30K
Filing ↗ - CHECKMATE GOVERNMENT RELATIONSPHIBRO ANIMAL HEALTH CORPORATION · 2026 Q2 · ANI, SCI$150K
Filing ↗ - MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M & W GOVERNMENT AFFAIRS, LLC)PHIBRO ANIMAL HEALTH CORPORATION · 2026 Q1 · AGR$30K
Filing ↗ - CHECKMATE GOVERNMENT RELATIONSPHIBRO ANIMAL HEALTH CORPORATION · 2026 Q1 · ANI, SCI$150K
Filing ↗ - MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M & W GOVERNMENT AFFAIRS, LLC)PHIBRO ANIMAL HEALTH CORPORATION · 2025 Q4 · AGR$30K
Filing ↗
Government Contracts
Federal awards to PHIBRO ANIMAL HEALTH CORP · USAspending
No federal contract awards found for PHIBRO ANIMAL HEALTH CORP.
U.S. Patents
Recent USPTO applications naming PHIBRO ANIMAL HEALTH CORP
No USPTO patent applications found for PHIBRO ANIMAL HEALTH CORP.
Annual Financials
From PAHC's 10-K filings · XBRL
No annual XBRL figures on record for PAHC. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in PAHC's price history.
Material Events (8-K)
Corporate events filed with the SEC
About PHIBRO ANIMAL HEALTH CORP
From SEC EDGAR company records
Overview Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. We market approximately 790 product lines in approximately 90 countries to approximately 4,800 customers. We develop, manufacture and market a broad range of products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. Our products help prevent, control and treat diseases and support nutrition to help improve a…
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersTEANECK, NJ
IncorporatedDE
SEC CIK0001069899 ↗
Former namesPHILIPP BROTHERS CHEMICALS INC